spec sheet12 rows
Vincamine is a monoterpenoid indole alkaloid obtained mainly from the leaves of the lesser periwinkle (Vinca minor). It has been used as a cerebral vasodilator to improve blood flow to the brain and is taken for cognitive and cerebrovascular complaints, being available in parts of Europe as a prescription vasodilator and elsewhere as a dietary supplement. It is best known as the parent compound of the semisynthetic derivative vinpocetine.
- Widens brain blood vessels
- Increases cerebral blood flow
- Improves oxygen and metabolism
- Parent of vinpocetine
- Supports sharper thinking
- Nausea or digestive upset
- Dizziness
- Low blood pressure
Overview
Vincamine is a naturally occurring monoterpenoid indole alkaloid, one of the major alkaloids of the lesser periwinkle, Vinca minor, where it makes up a large share of the plant's indole alkaloids [1]. It can also be prepared by semisynthesis from related alkaloids such as tabersonine [1]. Chemically it belongs to the eburnamine-vincamine group of alkaloids found in the Apocynaceae plant family, a group whose members share effects on brain circulation and nerve-cell function [1].
Vincamine has long been used as a peripheral and cerebral vasodilator, given to increase blood flow to the brain [1]. In several European countries it is prescribed for cognitive decline linked to aging and cerebrovascular disease, including primary degenerative and vascular dementia [1]. In the United States it has instead been sold as a dietary-supplement ingredient, often in sustained-release form and marketed for memory and mental sharpness [1]. Laboratory studies of how the body handles it show that vincamine and related alkaloids cross the blood-brain barrier readily and interact only weakly with the transporters that pump drugs out of the brain [2].
Vincamine is most widely known as the starting point for vinpocetine, a semisynthetic derivative that has been developed and marketed far more extensively as a neuroprotective and cognition-enhancing agent [1]. In experimental comparisons of eburnamine-vincamine alkaloids, vincamine improved the early recovery of brain electrical activity after induced ischemia and produced a modest, short-lived rise in local cerebral blood flow [3]. Beyond the brain, chemists have used vincamine as a raw material to make derivatives with other activities, including compounds studied for anticancer effects [4].
The regulatory status of vincamine varies by country; it is available as a prescription vasodilator in parts of Europe, while in the United States it is treated as a supplement ingredient rather than an approved drug [1]. As with other centrally acting vasodilators, the clinical evidence for meaningful benefit in dementia is limited, and health authorities have raised questions about the safety of long-term use [1]. It is generally taken by mouth.
Mechanism
Vincamine is classed as a cerebral vasodilator, and its principal effect is to widen blood vessels and increase blood flow to the brain [1]. As one of the eburnamine-vincamine alkaloids, it modulates brain circulation and neuronal homeostasis and carries antihypoxic and neuroprotective properties, meaning it can help nerve tissue better tolerate periods of low oxygen [1]. In animal models of cerebral insufficiency, vincamine improved the early recovery of cortical electrical activity following a temporary loss of blood supply and briefly raised local cerebral blood flow, without greatly changing the brain's energy stores [3].
Studies of its pharmacokinetics show that vincamine is readily taken up into the brain, crossing the with little resistance from drug efflux transporters [2]. Its close chemical relatives, in particular the derivative vinpocetine, act on similar targets such as calmodulin-dependent phosphodiesterase and ion channels, and vincamine is understood to work broadly within this same pharmacological family [1].
receptor fingerprint
Phosphodiesteraseinhibits
Voltage-gated calcium channelsblocks
/ modulates
Dosingtypical ranges, not medical advice
interested in protocols and clinical dosages? make an account to see them! ^_^
Safetyrisks and cautions, not medical advice
Avoid vincamine if you have a brain tumor, raised intracranial pressure, are pregnant, or are hypersensitive to it. Be careful with blood pressure meds and other CNS-active drugs, since it can deepen low blood pressure. It's usually prescription-only in Europe and not scheduled internationally.
History
Vincamine is a monoterpenoid indole alkaloid obtained from the lesser periwinkle, Vinca minor, a plant long used in European folk medicine. It was isolated and characterized in the mid-1950s, and by the 1960s it had been developed into a pharmaceutical marketed in Europe as a cerebral vasodilator intended to improve blood flow and oxygenation in the aging brain, seeing use for symptoms attributed to cerebrovascular insufficiency. Its natural scarcity and pharmacological interest spurred medicinal chemistry around the scaffold, most notably yielding the semisynthetic derivative vinpocetine, which became more widely known than the parent alkaloid. Vincamine itself continued to be sold in various formulations, chiefly in continental Europe, as a geriatric cerebral circulation agent.
Reputation
Vincamine is regarded as a classic old-school European nootropic and cerebral vasodilator, respected for its long clinical history but viewed as dated by contemporary standards. Supporters value it for reported benefits to memory, concentration, and cerebral blood flow in older adults, and it retains a following among enthusiasts of vinca alkaloids. Skeptics note that much of its supporting evidence comes from older studies of variable rigor, that its relative vinpocetine has largely eclipsed it in popularity, and that its regulatory status varies, with availability as a prescription product in some countries and as a supplement or restricted substance in others. Overall it is seen as a historically important but modestly evidenced compound now overshadowed by its own derivative.
Subjective profileweighing the evidence above
Hard to recommend over its own descendant. The cognitive evidence is thin and dated, nausea and low blood pressure are common complaints, and vinpocetine is the better-characterised molecule that came out of it. Avoid entirely with raised intracranial pressure or in pregnancy.
Resources
This entry is here for reference.
Research
- 1986first citedA comparison of some of the pharmacological properties of the new eburnamenine derivative vinde…
- 2016most recentIn vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine…
- 1.Eburnamine derivatives and the brain
- 2.In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonine
- 3.A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
- 4.Synthesis of 15-methylene-eburnamonine from (+)-vincamine, evaluation of anticancer activity, and investigation of mechanism of action by quantitative NMR
4 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
What is vincamine?
It is a periwinkle-derived alkaloid and the parent compound of vinpocetine, used to support brain blood flow.
How does it relate to vinpocetine?
Vinpocetine is a semi-synthetic derivative of vincamine developed to improve on its properties.
What is its main proposed benefit?
It is thought to widen cerebral blood vessels, improving oxygen and nutrient delivery to the brain.
Where does it come from?
It is extracted from the lesser periwinkle plant, Vinca minor.
Limitations of the evidence
- Questions remain about the safety of long-term use
Adverse effects
- Nausea or digestive upset
- Dizziness
- Low blood pressure